Labline Instruments (India) Profile
Key Indicators
- Authorised Capital ₹ 0.50 M
- Paid Up Capital ₹ 0.50 M
- Company Age 11 Year, 5 Months
- Last Filing with ROC 31 Mar 2024
- Open Charges ₹ 7.00 M
- Satisfied Charges ₹ 0.45 M
- Revenue Growth -7.88%
- Profit Growth 485.59%
- Ebitda -8.73%
- Net Worth 6.71%
- Total Assets 14.29%
About Labline Instruments (India)
Labline Instruments (India) Private Limited (LIIPL) is a Private Limited Indian Non-Government Company incorporated in India on 29 August 2013 and has a history of 11 years and five months. Its registered office is in Amravati, Maharashtra, India.
The Company is engaged in the Healthcare Industry.
The Company's status is Active, and it has filed its Annual Returns and Financial Statements up until 31 March 2024. It's a company limited by shares with an authorized capital of Rs 0.50 M and a paid-up capital of Rs 0.50 M.
The company currently has active open charges totaling ₹7.00 M. The company has closed loans amounting to ₹0.45 M, as per Ministry of Corporate Affairs (MCA) records.
Raj Sewani, Shalini Sewani, Rajesh Sewani, and One other member serve as directors at the Company.
Company Details
-
Location
Amravati, Maharashtra, India
-
Telephone
+91-XXXXXXXXXX
-
Email Address
-
Website
-
-
Social Media-
Corporate Identity Details
-
CIN/LLPIN
U29248MH2013PTC247632
-
Company No.
247632
-
Company Classification
Private Limited Indian Non-Government Company
-
Incorporation Date
29 Aug 2013
-
Date of AGM
30 Sep 2024
-
Date of Balance Sheet
31 Mar 2024
-
Listing Status
Unlisted
-
ROC Code
Roc Mumbai
Industry
Who are the key members and board of directors at Labline Instruments (India)?
Board Members (4)
| Name | Designation | Appointment Date | Status |
|---|---|---|---|
Raj Sewani
|
Director | 29-Aug-2013 | Current |
|
Shalini Sewani
|
Director | 29-Aug-2013 | Current |
|
Rajesh Sewani
|
Director | 29-Aug-2013 | Current |
|
Shankar Sewani
|
Director | 29-Aug-2013 | Current |
Financial Performance of Labline Instruments (India).
Labline Instruments (India) Private Limited, for the financial year ended 2023, experienced Minor drop in revenue, with a 7.88% decrease. The company also saw a substantial improvement in profitability, with a 485.59% increase in profit. The company's net worth moved up by a moderate rise of 6.71%.
- Key Matrics
- Balance Sheet
- Profit and Loss
- Cash Flow
- Ratios
| Metrics |
|
(FY 2022) | (FY 2021) | (FY 2020) | (FY 2019) | ||
|---|---|---|---|---|---|---|---|
| Total Revenue |
|
||||||
| Revenue from Operations |
|
||||||
| Total Assets |
|
||||||
| Profit or Loss |
|
||||||
| Net Worth |
|
||||||
| EBITDA |
|
What is the Ownership and Shareholding Structure of Labline Instruments (India)?
In 2023, Labline Instruments (India) had a promoter holding of 100.00%. Access key insights, ownership, including shareholding patterns, funding, foreign investors, KMP remuneration, group structure, and overseas investments.
Charges (Loans)
₹7.00 M
₹0.45 M
Charges Breakdown by Lending Institutions
- Others : 0.70 Cr
Latest Charge Details
| Date | Lender | Amount | Status |
|---|---|---|---|
| 22 Jan 2021 | Others | ₹7.00 M | Open |
| 03 Mar 2016 | Bank Of India | ₹0.45 M | Satisfied |
How Many Employees Work at Labline Instruments (India)?
Unlock and access historical data on people associated with Labline Instruments (India), such as employment history, contributions to the Employees' Provident Fund Organization (EPFO), and related information.
Deals i
Gain comprehensive insights into the Deals and Valuation data of Labline Instruments (India), offering detailed information on various transactions, including security allotment data. Explore the intricate details of financial agreements, mergers, acquisitions, divestitures, and strategic partnerships that have shaped Labline Instruments (India)'s trajectory.
Rating
Access the credit rating data, providing valuable insights into the company's creditworthiness and financial stability. Explore assessments from leading credit rating agencies, evaluating factors such as debt obligations, liquidity, profitability, and overall financial health.
Alerts
Stay informed about regulatory alerts and litigation involving and associated companies. Receive timely updates on legal proceedings, regulatory changes, and compliance issues that may impact the company's operations, reputation, and financial performance. Monitor litigation involving subsidiaries, joint ventures, and other affiliated entities to assess potential risks and liabilities.